Literature DB >> 8988494

Long-term outcome in infants with the shaking-impact syndrome.

A C Duhaime1, C Christian, E Moss, T Seidl.   

Abstract

Nonaccidental injury accounts for nearly one quarter of all hospital admissions for head injury in infancy, and is associated with significant morbidity and mortality. Long-term outcome in survivors, however, has been incompletely studied. In this series, 84 infants 2 years of age and younger with the shaking-impact syndrome consecutively admitted to a single hospital between 1978 and 1988 were identified. A questionnaire detailing current medical, developmental, and behavioral status was developed, and attempts were made to locate the 62 children surviving the acute injury. Family instability and strict confidentiality restrictions precluded locating the majority of children, but 14 children with demographic and injury characteristics similar to those of the overall group were contacted at an average of 9 years after injury. Seven children were severely disabled or vegetative, 2 were moderately disabled, and 5 had a good outcome. Of the latter group, 3 had repeated grades and/or required tutoring. Acute factors associated with poor outcome included unresponsiveness on admission, need for intubation, age less than 6 months, and bilateral or unilateral diffuse hypodensity on CT scan. All children with bilateral diffuse hypodensity and loss of gray-white differentiation on CT scan remained blind, retarded, nonverbal, and nonambulatory in spite of aggressive medical and surgical management. This study suggests that the majority of children surviving the shaking-impact syndrome suffer major permanent morbidity, and that acute factors predicting long-term outcome may help guide aggressiveness of care.

Entities:  

Mesh:

Year:  1996        PMID: 8988494     DOI: 10.1159/000121058

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  31 in total

Review 1.  Pediatric neurocritical care.

Authors:  Sarah Murphy
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  A 12-year ophthalmologic experience with the shaken baby syndrome at a regional children's hospital.

Authors:  J D Kivlin
Journal:  Trans Am Ophthalmol Soc       Date:  1999

3.  Joint statement on Shaken Baby Syndrome.

Authors: 
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

4.  Diagnostic Performance of Ultrafast Brain MRI for Evaluation of Abusive Head Trauma.

Authors:  S F Kralik; M Yasrebi; N Supakul; C Lin; L G Netter; R A Hicks; R A Hibbard; L L Ackerman; M L Harris; C Y Ho
Journal:  AJNR Am J Neuroradiol       Date:  2017-02-09       Impact factor: 3.825

5.  Incidence and Risk Factors for Abusive Head Trauma: A Population-Based Study.

Authors:  Rebecca Rebbe; Joseph A Mienko; Melissa L Martinson
Journal:  Child Abuse Rev       Date:  2020-06-21

6.  Functional outcomes in children with abusive head trauma receiving inpatient rehabilitation compared with children with nonabusive head trauma.

Authors:  Sarah R Risen; Stacy J Suskauer; Ellen J Dematt; Beth S Slomine; Cynthia F Salorio
Journal:  J Pediatr       Date:  2013-12-08       Impact factor: 4.406

7.  Shaken baby syndrome in Canada: clinical characteristics and outcomes of hospital cases.

Authors:  W James King; Morag MacKay; Angela Sirnick
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262

8.  Low birth weight as a risk factor for seizure following acute subdural hematoma.

Authors:  Satoshi Kurabe; Takatoshi Sorimachi; Osamu Sasaki; Tetsuo Koike; Yukihiko Fujii
Journal:  Childs Nerv Syst       Date:  2009-04-18       Impact factor: 1.475

9.  [Shaken baby syndrome].

Authors:  W Reith; T Rohrer; F Ahlhelm; P Papanagiotou
Journal:  Radiologe       Date:  2009-10       Impact factor: 0.635

10.  Incidence and risk factors for perioperative hyperglycemia in children with traumatic brain injury.

Authors:  Deepak Sharma; Jill Jelacic; Rohini Chennuri; Onuma Chaiwat; Wayne Chandler; Monica S Vavilala
Journal:  Anesth Analg       Date:  2009-01       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.